Technical, bioinformatical and statistical aspects of liquid chromatography-mass spectrometry (LC-MS) and capillary electrophoresis-mass spectrometry (CE-MS) based clinical proteomics: a critical assessment.

Technical, bioinformatical and statistical aspects of liquid chromatography-mass spectrometry (LC-MS) and capillary electrophoresis-mass spectrometry (CE-MS) based clinical proteomics: a critical assessment.

Item

http://www.wikidata.org/entity/Q34880595

Q34880595

about

Mass spectrometry-based proteomics for pre-eclampsia and preterm birth Seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced disease Proteomics, lipidomics, metabolomics: a mass spectrometry tutorial from a computer scientist's point of view Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease Urinary proteomics as a novel tool for biomarker discovery in kidney diseases.Addressing the challenge of defining valid proteomic biomarkers and classifiers.i-RUBY: a novel software for quantitative analysis of highly accurate shotgun-proteomics liquid chromatography/tandem mass spectrometry data obtained without stable-isotope labeling of proteins.Protein interactome of muscle invasive bladder cancer.Capillary zone electrophoresis-electrospray ionization-tandem mass spectrometry as an alternative proteomics platform to ultraperformance liquid chromatography-electrospray ionization-tandem mass spectrometry for samples of intermediate complexity.iMet-Q: A User-Friendly Tool for Label-Free Metabolomics Quantitation Using Dynamic Peak-Width Determination.Urinary Proteomics Pilot Study for Biomarker Discovery and Diagnosis in Heart Failure with Reduced Ejection Fraction.Comparison of different statistical approaches for urinary peptide biomarker detection in the context of coronary artery disease.Prediction of acute coronary syndromes by urinary proteome analysis.Analytical glycobiology at high sensitivity: current approaches and directions Acute kidney injury prediction in cardiac surgery patients by a urinary peptide pattern: a case-control validation study.Tomato Juice Consumption Modifies the Urinary Peptide Profile in Sprague-Dawley Rats with Induced Hepatic Steatosis.Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?High-sensitivity analytical approaches for the structural characterization of glycoproteins.Industrialized MS-based proteomics in the search for circulating biomarkers.Catch me if you can: mass spectrometry-based phosphoproteomics and quantification strategies.CE-MS in biomarker discovery, validation, and clinical application.Urinary proteomics in cardiovascular disease: Achievements, limits and hopes.Recent developments in CE and CEC of peptides (2009-2011).Proteomics in hypertension and other cardiovascular diseases.On-line CE/ESI/MS interfacing: recent developments and applications in proteomics.Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications.Clinical applications of capillary electrophoresis coupled to mass spectrometry in biomarker discovery: Focus on Bladder Cancer.Urinary proteomics and molecular determinants of chronic kidney disease: possible link to proteases.Proteomic biomarkers in kidney disease: issues in development and implementation.Epidemiologic design and analysis for proteomic studies: a primer on -omic technologies.Body fluid peptide and protein signatures in diabetic kidney diseases.Urinary proteome analysis for prostate cancer diagnosis: cost-effective application in routine clinical practice in Germany.Novel Urinary Peptidomic Classifier Predicts Incident Heart Failure.Diagnosis of subclinical and clinical acute T-cell-mediated rejection in renal transplant patients by urinary proteome analysis.Use of monolithic supports for high-throughput protein and peptide separation in proteomics.Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer.Urine proteome analysis in heart failure with reduced ejection fraction complicated by chronic kidney disease: feasibility, and clinical and pathogenetic correlates.Urinary proteomic biomarkers to predict cardiovascular events

P2860

Q28083761-B7AF8DB8-67F3-4649-BA39-A32AF33F8D48 Q28534235-2E3D688F-D953-43A8-A4B5-CFC63D9DCEF1 Q28655356-C60B64B9-77F2-4B67-B22D-DBD85BA6F1E7 Q33591146-A02F5A2F-625E-4FBC-A256-63DFFF389BA5 Q33781011-45A0CF63-B1A6-4F7C-BBF0-B1FE9B5207B1 Q33786157-C263EADE-86C6-40A6-8820-F7C9BE0F6AC8 Q33849939-A09A1EDC-20B1-4087-947B-8E7432F45A87 Q34876528-B864D5DE-A034-43DA-A2A2-B622EE581E83 Q35751409-58731F27-5486-4A36-AA4E-F309D6DAD8B4 Q35897656-ADDB2A3A-15BE-4481-B533-F7C2B304006D Q36053833-B41ED553-D412-44AD-9378-9E70550E2C6F Q36214366-1FCBCFC4-2F05-476C-A610-9CD936D45CE0 Q36300622-5B63D043-8806-488A-B885-C979A23D1811 Q36651493-4AABDF2F-2684-44BD-9F6F-4CCAA9793AAF Q36942126-FA972E00-30C5-4EE2-98A3-153594F6F553 Q37465366-99879BC2-211C-4AB0-90A6-3F3FFCCA795E Q37702279-56A88E91-78D8-4045-BE3A-95123B77202E Q37712517-E2B57732-E40C-413D-979F-6D1B126DDC0E Q37810154-218A176A-EC45-4AE4-8B00-EE4DABDAB55A Q37827835-9674E099-5CFE-4AD4-818B-6B6423032DBF Q37833587-536B5FFA-5697-4204-BA33-4CD4B10A757F Q37869464-98165114-66B5-431D-B9FC-57A1D2698D01 Q37964561-2ABA7BC5-BCE2-46B4-A0AB-C68113B8AE26 Q38020003-F3038815-04C7-4205-AD7B-51ECF58AA8C8 Q38034203-12BAE4E7-2B54-4E80-92E3-7FD11FECC635 Q38091336-41C82520-0C0F-4F92-9D44-DD9F76BE4EA5 Q38130892-6E7F3A61-B6E0-4B24-AC34-6C9F176B8595 Q38222628-7736D47A-2066-4D34-94C5-106B92CB2D5F Q38341211-576A4EDC-6193-4062-BAD0-7D72DE8E8D15 Q38384848-ACD394D8-525D-4BDB-BAFA-B1C3D4CF485E Q38553924-EE29BAE1-9077-4A2A-8502-14D65C4EC806 Q40008598-350B33A2-61CC-4B4B-8201-DCC49CB37A55 Q40091740-4688C0F3-86E4-446A-ABAD-9DACA4C35D20 Q46474917-CC0DF8A1-8501-4AAD-B22A-26792B9D0F2A Q47803524-21ABCBF9-5AD3-461F-B764-DBD07F935DD8 Q50256258-0C156DAD-CA26-4AF3-A66D-4782EA0880DC Q50639398-7D022C55-3C69-4595-96D5-5D41CC5A0DD3 Q56970450-DF28FA88-8401-400D-817F-1EB5C55E72B5

P2860

Technical, bioinformatical and statistical aspects of liquid chromatography-mass spectrometry (LC-MS) and capillary electrophoresis-mass spectrometry (CE-MS) based clinical proteomics: a critical assessment.

Item

http://www.wikidata.org/entity/Q34880595

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu